Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Wesolowski

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
JCI Insight|November 8, 2024
Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumorsEmily Schwarz, Brooke Benner, Robert Wesolowski, et al.
NPJ Breast Cancer|December 30, 2022
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013Foluso O Ademuyiwa, Feng Gao, Cherease R Street, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2019
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative ChemotherapyAdrienne G Waks, Daniel G Stover, Jennifer L Guerriero, et al.
BMC Cancer|May 19, 2021
Genomic features of rapid versus late relapse in triple negative breast cancerYiqing Zhang, Sarah Asad, Zachary Weber, et al.
JMIR Cancer|May 19, 2022
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational StudyMaitri Kalra, Elizabeth Henry, Kelly McCann, et al.
Nature Communications|May 15, 2026
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trialAna C Garrido-Castro, Noah Graham, Katelyn X Li, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
JCI Insight|November 8, 2024
Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumorsEmily Schwarz, Brooke Benner, Robert Wesolowski, et al.
NPJ Breast Cancer|December 30, 2022
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013Foluso O Ademuyiwa, Feng Gao, Cherease R Street, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2019
The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative ChemotherapyAdrienne G Waks, Daniel G Stover, Jennifer L Guerriero, et al.
BMC Cancer|May 19, 2021
Genomic features of rapid versus late relapse in triple negative breast cancerYiqing Zhang, Sarah Asad, Zachary Weber, et al.
JMIR Cancer|May 19, 2022
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational StudyMaitri Kalra, Elizabeth Henry, Kelly McCann, et al.
Nature Communications|May 15, 2026
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trialAna C Garrido-Castro, Noah Graham, Katelyn X Li, et al.
Pageof 14